Related Experiment Video
Updated: Oct 10, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with
Takeshi Hatanaka1, Satoru Kakizaki2,3, Takuya Kaburagi1
1Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Japan.
Insights
This study reports the first identification of Hepatitis C Virus (HCV) subtype 1g in Japan. The patient, infected with a drug-resistant strain, was successfully treated with glecaprevir/pibrentasvir combination therapy.
Area of Science:
- Virology
- Hepatology
- Infectious Diseases
Background:
- Chronic Hepatitis C (HCV) is a significant global health concern.
- HCV exhibits remarkable genetic diversity, with numerous subtypes and quasispecies.
- Understanding HCV subtype distribution is crucial for epidemiological tracking and treatment strategies.
Observation:
- A 66-year-old male patient with chronic Hepatitis C (HCV) infection was identified.
- The patient had a history of plasma exchange in Egypt 30 years prior for falciparum malaria.
- Analysis revealed the presence of HCV subtype 1g, a novel finding in Japan.
Findings:
- Phylogenetic analysis confirmed the patient's HCV infection as subtype 1g.
- The identified HCV strain possessed naturally occurring resistance-associated substitutions in the NS3 and NS5A regions.
- Successful treatment was achieved using a combination therapy of glecaprevir/pibrentasvir.
Implications:
- This case marks the first documented instance of HCV subtype 1g in Japan.
- The findings highlight the importance of molecular diagnostics for identifying rare HCV subtypes.
- Effective treatment of drug-resistant HCV subtypes with direct-acting antivirals is feasible.
Abstract:
A 66-year-old man, who had undergone plasma exchange 30 years previously in Egypt for the treatment of falciparum malaria, was referred to our hospital for treatment of chronic hepatitis C (HCV). An analysis of the 655-nucleotide 5'-untranslated region-core region sequence revealed infection with HCV subtype 1g. A phylogenetic analysis of the full-length HCV genome confirmed that the patient's HCV was subtype 1g, which was the first case identified in Japan. Although his HCV possessed several naturally occurring resistance-associated substitutions in the nonstructural (NS) 3 and NS5A regions, he was successfully treated by combination therapy with glecaprevir/pibrentasvir.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Subviral Agents
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

